The European Commission's antitrust body said Friday it has cleared U.S. technology firm Danaher Corp. (DHR) to buy medical testing company Beckman Coulter (BEC).

The Commission concluded that the merged entity would continue to have significant rivals in the fields it covers and therefore the deal wouldn't harm competition in the European Union.

-By Laurence Norman, Dow Jones Newswires; 32-2741-1481; laurence.norman@dowjones.com

Beckman Coulter (NYSE:BEC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Beckman Coulter
Beckman Coulter (NYSE:BEC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Beckman Coulter